In vitro cell-based potency assay
US-2026098813-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Yie Junming patents
Yie Junming is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Yie Junming |
| Total patents | 19 |
| First publication | Feb 21, 2017 |
| Latest publication | Apr 9, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2025376529-A1 · Dec 11, 2025 · US
Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)
US-2025121056-A1 · Apr 17, 2025 · US
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
US-12252540-B2 · Mar 18, 2025 · US
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)
US-12214051-B2 · Feb 4, 2025 · US
Functional cell-based potency assay for measuring biological activity of interleukin 2 (il-2) analogs
US-2024255492-A1 · Aug 1, 2024 · US
Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
US-11248052-B2 · Feb 15, 2022 · US
Cell-based bioidentity test for insulin
US-2022026414-A1 · Jan 27, 2022 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2022025059-A1 · Jan 27, 2022 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
US-11046774-B2 · Jun 29, 2021 · US
Recent patents
Latest publications not already listed above.
Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)
US-2021154318-A1 · May 27, 2021 · US
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)
US-10905772-B2 · Feb 2, 2021 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2019276546-A1 · Sep 12, 2019 · US
Human Antigen Binding Proteins That Bind to a Complex Comprising Beta-Klotho and an FGF Receptor
US-2019248906-A1 · Aug 15, 2019 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
US-10294303-B2 · May 21, 2019 · US
Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)
US-2018311372-A1 · Nov 1, 2018 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2017275370-A1 · Sep 28, 2017 · US
Human Antigen Binding Proteins That Bind To a Complex Comprising beta-Klotho and an FGF Receptor
US-2017183412-A1 · Jun 29, 2017 · US
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
US-9574002-B2 · Feb 21, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 16 |
| Merck Sharp & Dohme Llc | 2 |
| Li Yang | 1 |
| Stevens Jennitte | 1 |
| King Chadwick Terence | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/565 | 16 |
| A61P3/10 | 16 |
| A61P3/04 | 16 |
| A61P3/00 | 16 |
| A61K38/26 | 12 |